Date | Time | Source | Headline | Symbol | Company |
07/29/2024 | 1:07PM | iHub Newswire | FeaturedCannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA | | |
01/26/2010 | 4:52PM | Dow Jones News | Gilead Sciences 4Q Profit Up 43% On Strong HIV Drug Sales | NASDAQ:GILD | Gilead Sciences Inc |
01/26/2010 | 4:14PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
01/26/2010 | 4:05PM | Business Wire | Gilead Sciences Announces Record Fourth Quarter and Full Year 2009 Financial Results | NASDAQ:GILD | Gilead Sciences Inc |
01/20/2010 | 9:31AM | PR Newswire (US) | Critical Alerts for AIG, Procter & Gamble, Gilead Sciences, Thermo Fisher Scientific, and AstraZeneca Released by Seven Summits | NASDAQ:GILD | Gilead Sciences Inc |
01/20/2010 | 4:00AM | Marketwired | (OTCBB: GELV) Receives BUY Rating and $.41 Price Target | NASDAQ:GILD | Gilead Sciences Inc |
01/19/2010 | 4:30PM | Business Wire | Gilead Sciences to Release Fourth Quarter and Year End 2009 Financial Results on Tuesday, January 26, 2010 | NASDAQ:GILD | Gilead Sciences Inc |
01/19/2010 | 9:38AM | Marketwired | Wall Street News Alert: Trade Alert: Wound Management Technologies -- January 19, 2010 | NASDAQ:GILD | Gilead Sciences Inc |
01/14/2010 | 5:56PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
01/07/2010 | 9:15AM | Marketwired | Market Pulse Announces Its Stock Alerts for Thursday, January 7, 2010: ARYC -- Arrayit Corporation Announces a NEW Pre-Symptomat | NASDAQ:GILD | Gilead Sciences Inc |
01/06/2010 | 5:38PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
01/06/2010 | 8:30AM | Business Wire | Phase II Clinical Trial of Gilead’s Investigational Integrase-Based, Once-Daily, Fixed-Dose “Quad” Regimen Meets 24-Wee... | NASDAQ:GILD | Gilead Sciences Inc |
01/04/2010 | 4:30PM | Business Wire | Gilead Sciences to Present at Two Upcoming Investor Conferences | NASDAQ:GILD | Gilead Sciences Inc |
12/28/2009 | 8:13PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
12/21/2009 | 6:01AM | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (S-8) | NASDAQ:GILD | Gilead Sciences Inc |
12/21/2009 | 6:01AM | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NASDAQ:GILD | Gilead Sciences Inc |
12/17/2009 | 9:31AM | PR Newswire (US) | Critical Alerts for AMD, Gilead, Netflix, Electronic Arts, and Constellation Brands Released by Seven Summits Research | NASDAQ:GILD | Gilead Sciences Inc |
12/15/2009 | 4:29PM | DPA AFX Nachrichten | ROUNDUP/Aktien New York Schluss: Verluste - Inflationssorgen belasten | NASDAQ:GILD | Gilead Sciences Inc |
12/15/2009 | 11:20AM | DPA AFX Nachrichten | ROUNDUP/Aktien New York: Kaum verändert | NASDAQ:GILD | Gilead Sciences Inc |
12/15/2009 | 8:42AM | DPA AFX Nachrichten | Aktien New York Ausblick: Etwas schwächer erwartet – Zahlreiche Daten im Blick | NASDAQ:GILD | Gilead Sciences Inc |
12/14/2009 | 7:43PM | Business Wire | Second Pivotal Phase III Study of Gilead’s Darusentan for Resistant Hypertension Misses Primary Endpoints | NASDAQ:GILD | Gilead Sciences Inc |
12/10/2009 | 6:06PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
12/10/2009 | 4:46PM | Business Wire | FDA Advisory Committee Supports Use of Aztreonam for Inhalation Solution for Patients With Cystic Fibrosis | NASDAQ:GILD | Gilead Sciences Inc |
12/10/2009 | 4:01PM | Dow Jones News | UPDATE: FDA Panel Backs Gilead Antibiotic For Cystic Fibrosis | NASDAQ:GILD | Gilead Sciences Inc |
12/10/2009 | 3:23PM | Dow Jones News | FDA Panel Backs Gilead Antibiotic For Cystic Fibrosis | NASDAQ:GILD | Gilead Sciences Inc |
12/08/2009 | 11:38AM | Dow Jones News | Gilead Seeking FDA Panel Backing Of Inhaled Antibiotic | NASDAQ:GILD | Gilead Sciences Inc |
12/03/2009 | 3:53PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
12/03/2009 | 3:53PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
12/03/2009 | 3:52PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
12/01/2009 | 5:50PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |